Virtual Reality in Children with and Without Vestibular Deficits
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 8, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of virtual reality (VR) to help children with and without vestibular deficits, which are conditions affecting balance and spatial awareness. The goal is to create a fun and engaging way to assess and improve how these children coordinate their movements, particularly their hand-eye coordination. By using VR technology, researchers hope to better understand how children process sensory information—like what they see and feel—in relation to their surroundings. This could lead to new and effective treatment methods for those with balance issues.
To participate in the study, children aged 7 to 17 years who have vestibular problems or are healthy volunteers may be eligible. Participants will be asked to engage with VR activities that are safe and enjoyable. However, children with certain eye or neurological conditions may not be included. This trial aims to establish a reliable and age-appropriate VR protocol that could ultimately benefit many young patients by enhancing their quality of life and developmental outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minors aged 7 to 17 years (inclusive)
- • Volunteers adult
- • Information and consent of holders of parental authority of minors, minors and of adult subjects
- Patients :
- • Presence of unilateral or bilateral chronic vestibular pathology
- • Minor patients followed in consultation at Necker Hospital in the Pediatric ENT department
- • Adult patients followed at adult vestibulometry services (Lariboisière and Pitié Salpêtrière Hospitals)
- Controls:
- • No history of otological surgery and absence of vestibular pathology
- • Patients followed in consultation at Necker Hospital, siblings or adult parents
- Exclusion Criteria:
- • Presence of an ophthalmological pathology (including refractive errors)
- • Presence of neurological pathology including epilepsy or any pathology that can alter mobility and interfere with the performance of tasks
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Françoise Denoyelle, MD, PhD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
François SIMON, MD, PhD
Study Director
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials